Santhera Pharmaceuticals Quote - 0QN1

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Current Price

190.20

Bid

0.00

Offer

0.00

Volume

4,661

0.00 Day's Range 0.00

190.20 52 Week Range 190.20

Market Cap

2.152B

Previous Close

190.20

Open

Last Trade

206

14.68

(O)

Last Trade Time

Financial Volume

VWAP

Average Volume (3m)

505

Shares Outstanding

11,315,000

Dividend Yield

PE Ratio

1.95

Earnings Per Share (EPS)

4.84

Revenue

103.41M

Net Profit

54.78M

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.santhera.com

Headquarters

Liestal, Che

Founded

Santhera Pharmaceuticals Holding Ag is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker 0QN1. The last closing price for Santhera Pharmaceuticals was CHF190.20. Over the last year, Santhera Pharmaceuticals shares have traded in a share price range of CHF 190.20 to CHF 190.20.

Santhera Pharmaceuticals currently has 11,315,000 shares in issue. The market capitalisation of Santhera Pharmaceuticals is CHF2.15 billion. Santhera Pharmaceuticals has a price to earnings ratio (PE ratio) of 1.95.

Santhera publiziert Zeitplan für die Aktienzusammenlegung

Santhera publiziert Zeitplan für die Aktienzusammenlegung NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN THE UNITED STATES OR ANY OTHER JURISDICTION IN WHICH IT WOULD BE UNLAWFUL TO DO SO...

Shareholders Approve all Board Proposals at Today’s Annual General Meeting

Shareholders Approve all Board Proposals at Today’s Annual General Meeting Pratteln, Switzerland, June 27, 2023 – Santhera Pharmaceuticals (SIX: SANN) announces that its shareholders approved...

Santhera vergibt exklusive Nordamerika-Lizenz für Vamorolone an Catalyst Pharmaceuticals in einer Transaktion im Wert von bis zu USD 231 Millionen zuzüglich Lizenzgebühren

Santhera vergibt exklusive Nordamerika-Lizenz für Vamorolone an Catalyst Pharmaceuticals in einer Transaktion im Wert von bis zu USD 231 Millionen zuzüglich Lizenzgebühren Ad-hoc-Mitteilung...

Santhera Publishes Agenda for its Annual General Meeting

Santhera Publishes Agenda for its Annual General Meeting NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN THE UNITED STATES OR ANY OTHER JURISDICTION IN WHICH IT WOULD BE UNLAWFUL TO DO SO...

Santhera veröffentlicht Jahresbericht 2022

Santhera veröffentlicht Jahresbericht 2022 Ad-hoc-Mitteilung gemäss Art. 53 KR Pratteln, Schweiz, 31. Mai 2023 – Santhera Pharmaceuticals (SIX: SANN) gibt die Veröffentlichung des...

Period	Open	High	Low	Avg. Daily Vol	VWAP
1	190.2	190.2	190.2	831	190.2	DE
4	190.2	190.2	190.2	1019	190.2	DE
12	190.2	190.2	190.2	505	190.2	DE
26	190.2	190.2	190.2	334	190.2	DE
52	190.2	190.2	190.2	436	190.2	DE
156	190.2	190.2	190.2	1843	190.2	DE
260	190.2	190.2	190.2	1736	190.2	DE

0QN1 - Frequently Asked Questions (FAQ)

What is the current Santhera Pharmaceuticals share price?

The current share price of Santhera Pharmaceuticals is CHF 190.20

How many Santhera Pharmaceuticals shares are in issue?

Santhera Pharmaceuticals has 11,315,000 shares in issue

What is the market cap of Santhera Pharmaceuticals?

The market capitalisation of Santhera Pharmaceuticals is CHF 2.15B

What is the 1 year trading range for Santhera Pharmaceuticals share price?

Santhera Pharmaceuticals has traded in the range of CHF 190.20 to CHF 190.20 during the past year

What is the PE ratio of Santhera Pharmaceuticals?

The price to earnings ratio of Santhera Pharmaceuticals is 1.95

What is the cash to sales ratio of Santhera Pharmaceuticals?

The cash to sales ratio of Santhera Pharmaceuticals is 1.03

What is the reporting currency for Santhera Pharmaceuticals?

Santhera Pharmaceuticals reports financial results in CHF

What is the latest annual turnover for Santhera Pharmaceuticals?

The latest annual turnover of Santhera Pharmaceuticals is CHF 103.41M

What is the latest annual profit for Santhera Pharmaceuticals?

The latest annual profit of Santhera Pharmaceuticals is CHF 54.78M

What is the registered address of Santhera Pharmaceuticals?

The registered address for Santhera Pharmaceuticals is HAMMERSTRASSE 49, LIESTAL, 4410

What is the Santhera Pharmaceuticals website address?

The website address for Santhera Pharmaceuticals is www.santhera.com

Which industry sector does Santhera Pharmaceuticals operate in?

Santhera Pharmaceuticals operates in the PHARMACEUTICAL PREPARATIONS sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
TCFTheracryf Plc	0.725p (38.10%)	7.56M
NMTNeometals Ltd	3.50p (27.27%)	346.81k
SCHOScholium Group Plc	44.00p (25.71%)	30.65k
FABFusion Antibodies Plc	10.15p (24.54%)	3.34M
PYXPyx Resources Limited	3.49p (22.24%)	8.43k
TM1Technology Minerals Plc	0.125p (-24.24%)	37.21M
QUIZQuiz Plc	0.70p (-18.60%)	3.67M
SYMESupply@me Capital Plc	0.003p (-17.81%)	168.35M
OBDOxford Biodynamics Plc	1.20p (-14.29%)	827.83k
ZENZenith Energy Ltd.	5.25p (-13.93%)	5.39M
TRPTower Resources Plc	0.0395p (5.33%)	539.51M
CPXCap-xx Limited	0.1825p (1.39%)	494M
NTVONativo Resources Plc	0.0019p (0.00%)	320.16M
DGIDg Innovate Plc	0.0225p (-13.46%)	208.21M
ENETEthernity Networks Ltd	0.1125p (2.27%)	207.56M